Search

everythinglearnresearchcommunity

for

Search:↓

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Androgenetic alopecia involves a fungal imbalance in hair follicles, suggesting potential for microbiome-targeted treatments.

ASLNC168501 may help treat hair loss by boosting hair follicle stem cell activity.

Hair loss significantly affects quality of life and mental health, causing anxiety and depression.

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.

People with male pattern baldness are more likely to have metabolic syndrome.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

Human hair contains a substance that shows blood group A activity.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

The absence of functional sebaceous glands causes hair follicle destruction and scarring alopecia.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

Scalp nerve issues are linked to hair loss in men.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

AMT may be more effective than finasteride for hair growth in androgenetic alopecia.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

Alopecia areata affects about 2% of people and can impact any hair area.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

Men with early hair loss may have higher risks of insulin resistance and metabolic issues.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

TGFα gene mutation in mice causes abnormal skin, wavy hair, curly whiskers, and sometimes eye inflammation.

Adenosine helps grow thicker hair in Japanese men with hair loss.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.

Certain tyrosine kinases may regulate hair growth and could help develop hair loss treatments.